News

Dutch immunotherapy company ISA Pharmaceuticals has closed a €26m funding round that will go towards advancing its therapy targeting HPV16-related cancers. New investors of the company, which is located in Leiden Bio Science Park, including Invest-NL, joined existing investors, among them Regeneron. ISA will use the proceeds of this round to bring its lead product
0 Comments
PRINCETON, N.J.–(BUSINESS WIRE)–UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced that it expects net product revenue from Jelmyto sales for the second quarter ended June 30, 2021, to be approximately $13.0 million, representing an increase of over 70% compared
0 Comments
– Patent bolsters intellectual property protection as Company’s partner, MEDICE, works to develop and potentially commercialize ADAIR in Europe and the UK PHILADELPHIA, PA, July 13, 2021 (GLOBE NEWSWIRE) — Vallon Pharmaceuticals Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to
0 Comments
Start — a,.special_wrapbx a{color:#333;font:400 11px Lato,sans-serif}.user_after_login a, .user_before_login a {color: #333333;font: 11px ‘Lato’,sans-serif;}.dropdown-menu{display:none;background-clip:border-box!important}.header_desktop .dropdown-menuli{border-bottom:1px solid #e9e9e9}.header_desktop .dropdown-menulia{display:block;padding:10px;margin:0;font:13px Roboto,sans-serif;color:#333}.header_desktop .arrow,.lang_link{display:inline-block}.header_desktop .dropdown-menulia:hover{background:#30659f;color:#fff;border:none}.header_desktop .dropdown-menuli:last-child{border:none}.lan_dropbx{float:left;padding:10px 0}.special_wrapbx{float:left;margin-left:20px}.lang_link{font:400 11px Lato,sans-serif;color:#666!important}.main_header_wrapper{width:1260px; position: relative; margin:0 auto}.searchBox{width:424px;position:absolute;left:50%;top:2px;margin-left:-212px;border:1px solid #bababa;border-radius:17px;background-color:#fff;z-index:0;height:30px;z-index:999}.searchBox .searchboxInner{background:#fff;border:0;height:27px;margin:1px;border-radius:17px}.searchBox .searchboxInner .txtsrchbox{margin-top:0px;width:100%;border:0;outline:0;height:25px;border-radius:17px;padding:2px 30px 2px 15px;font:400 13px Lato,sans-serif}.common_dropmenu.dropdown-menu{margin:0;border-radius:0}.header_desktop .dropdown-menu{border:1px solid #e2e2e2;box-shadow:0 2px 5px rgba(0,0,0,.175)}.common_dropmenu:after,.common_dropmenu:before{bottom:100%;border:solid transparent;content:” “;height:0;width:0;position:absolute;pointer-events:none;left:20px}.header_desktop .arrow,.logo_wrapper{position:relative}.common_dropmenu:after{border-color:rgba(255,255,255,0);border-bottom-color:#fff;border-width:6px;margin-left:-6px}.common_dropmenu:before{border-color:rgba(209,211,214,0);border-bottom-color:#e2e2e2;border-width:8px;margin-left:-8px}.header_desktop .arrow{border:solid #707070;border-width:0 1px 1px 0;padding:2px;margin-left:3px;top:-2px; width: auto; height:
0 Comments
Texas Biomedical Research Institute and Aridis’ data confirmed AR-712 binds to and neutralizes the Delta variant of SARS-CoV-2 virus Binding analysis projects the ability of AR-712 to bind to all variants on the Centers for Disease Control’s Variants of Interest and Variants of Concern lists LOS GATOS, Calif., July 12, 2021 /PRNewswire/ — Aridis Pharmaceuticals,
0 Comments
Englewood Cliffs NJ, July 12, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO), a development stage biopharmaceutical company, today announced that it has entered into a Scientific Research Agreement with the University of Maryland, Baltimore.  The main objective of our study is to evaluate the pharmacokinetics of dexamethasone delivered to arthritic rats via liposomes.
0 Comments
The medicines developer has locked down a key approval to test its own offering against a multi-billion-dollar drug in a 12-week observational study into neuropathic pain. Zelira Therapeutics (ASX:ZLD) (OTCMKTS:ZALDF) has secured Institutional Review Board (IRB) approval for a pain observational trial to take place in the US. The cannabinoid medicines developer is set to
0 Comments
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, ‘The possibility of permanent loss is the risk I worry about… and every practical investor I know worries about.’ It’s only natural to consider a company’s balance sheet when you examine how risky it is, since debt is often
0 Comments
NEW YORK–(BUSINESS WIRE)–Jul 10, 2021– WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athira Pharma, Inc. (NASDAQ: ATHA): (a) pursuant and/or traceable to the Company’s initial public offering conducted in September 2020 (the “IPO” or “Offering”); and/or (b) between September 18, 2020 and June 17, 2021, both
0 Comments
DUBLIN, July 9, 2021 /PRNewswire/ — The “Global Animal Pharmaceuticals Market, By Product Type (Drugs, Vaccine, Medicated Feed), By Animal Type, By Route of Administration, By Type of Infection, By End User, By Distribution Channel, By Region, By Company, Forecast & Opportunities, 2026” report has been added to ResearchAndMarkets.com’s offering. The animal pharmaceuticals market was
0 Comments
French speciality vaccine company Valneva has announced that its single-shot chikungunya vaccine candidate has received a breakthrough therapy designation from the US Food and Drug Administration (FDA). The chikungunya vaccine – VLA1553 – has also previously been awarded an FDA fast track designation and a European Medicines Agency (EMA) PRIME designation, in December 2019 and
0 Comments
Rawalpindi : National University of Medical Sciences (NUMS) research will help the pharmaceutical industry to produce the first-ever ‘Healing Bandage’ in Pakistan which will quicken healing various kinds of wounds of the injured people across the country, said a young scientist of the university here Thursday. NUMS Department of Biological Sciences has already been awarded
0 Comments
New York Weather: CBS2’s 7/8 Thursday Afternoon UpdateElise Finch has the Tri-State Area’s latest forecast on CBS2 News At Noon. 36 minutes ago N.Y. AG James Announces $4.5 Billion Settlement With Purdue PharmaLetitia James announced the terms of a $4.5 billion settlement Thursday, resolving a years-long legal fight against Purdue Pharma in connection with the
0 Comments
More than a dozen states have dropped their longstanding objections to OxyContin maker Purdue Pharma’s reorganization plan, edging the company closer to resolving its bankruptcy case and transforming itself into a new entity that helps combat the U.S. opioid epidemic through its own profits. The agreement from multiple state attorneys general, including those who had
0 Comments
MARLBOROUGH, Mass., July 7, 2021 /PRNewswire/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced that it will participate in a Fireside Chat with H.C. Wainwright at 11 a.m. Eastern Time on Monday, July 12, 2021. Interested
0 Comments
Yesterday morning, senior leaders from patient groups and from the pharmaceutical industry, alongside the expert judges for the Patient Partnership Index 2021, joined together to discuss ‘what’s next for patient advocacy?’. Taking place on Tuesday 6th July, the free virtual event was hosted by Roudie Shafie, Director at specialist healthcare communications agency OVID Health which
0 Comments
Start — a,.special_wrapbx a{color:#333;font:400 11px Lato,sans-serif}.user_after_login a, .user_before_login a {color: #333333;font: 11px ‘Lato’,sans-serif;}.dropdown-menu{display:none;background-clip:border-box!important}.header_desktop .dropdown-menuli{border-bottom:1px solid #e9e9e9}.header_desktop .dropdown-menulia{display:block;padding:10px;margin:0;font:13px Roboto,sans-serif;color:#333}.header_desktop .arrow,.lang_link{display:inline-block}.header_desktop .dropdown-menulia:hover{background:#30659f;color:#fff;border:none}.header_desktop .dropdown-menuli:last-child{border:none}.lan_dropbx{float:left;padding:10px 0}.special_wrapbx{float:left;margin-left:20px}.lang_link{font:400 11px Lato,sans-serif;color:#666!important}.main_header_wrapper{width:1260px; position: relative; margin:0 auto}.searchBox{width:424px;position:absolute;left:50%;top:2px;margin-left:-212px;border:1px solid #bababa;border-radius:17px;background-color:#fff;z-index:0;height:30px;z-index:999}.searchBox .searchboxInner{background:#fff;border:0;height:27px;margin:1px;border-radius:17px}.searchBox .searchboxInner .txtsrchbox{margin-top:0px;width:100%;border:0;outline:0;height:25px;border-radius:17px;padding:2px 30px 2px 15px;font:400 13px Lato,sans-serif}.common_dropmenu.dropdown-menu{margin:0;border-radius:0}.header_desktop .dropdown-menu{border:1px solid #e2e2e2;box-shadow:0 2px 5px rgba(0,0,0,.175)}.common_dropmenu:after,.common_dropmenu:before{bottom:100%;border:solid transparent;content:” “;height:0;width:0;position:absolute;pointer-events:none;left:20px}.header_desktop .arrow,.logo_wrapper{position:relative}.common_dropmenu:after{border-color:rgba(255,255,255,0);border-bottom-color:#fff;border-width:6px;margin-left:-6px}.common_dropmenu:before{border-color:rgba(209,211,214,0);border-bottom-color:#e2e2e2;border-width:8px;margin-left:-8px}.header_desktop .arrow{border:solid #707070;border-width:0 1px 1px 0;padding:2px;margin-left:3px;top:-2px; width: auto; height:
0 Comments
Los Angeles, USA, July 05, 2021 (GLOBE NEWSWIRE) — Genital Herpes Pipeline Landscape: Insights into Emerging Therapies, Growth Variables, Commercial Assessment and Key Pharmaceutical Companies Active in the Space The Genital Herpes pipeline landscape offers a rich product portfolio with novel therapy MoAs such as Immunomodulators, Virus internalization inhibitors, DNA helicase-primase inhibitors, Immunostimulants, and others
0 Comments
Chemplast Sanmar and Tatva Chintan Pharma Chem have received capital markets regulator Sebi’s go ahead to raise Rs 3,950 crore collectively through initial share sales. Chennai-based Chemplast Sanmar filed preliminary IPO papers in May to raise Rs 3,500 crore, while specialty chemical manufacturing company Tatva Chintan Pharma Chem approached Sebi with its draft papers in
0 Comments
By Aditya Raghunath Investing.com — Orchid Pharma Ltd (NS:)’s share price trajectory since it got relisted in November is a classic example of retail investors getting caught with shares that are very difficult to exit. Orchid Pharma went through the NCLT (National Company Law Tribunal) last year and was acquired by Dhanuka Labs who owned
0 Comments